CVR number 40185720
Industry 75.0000 Veterinary activities

Grindsted Dyreklinik ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  15.2% 16.8% 16.4% 15.1% 19.3%  
Credit score (0-100)  14 10 10 12 6  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  3,972 3,102 2,963 2,719 2,573  
EBITDA  408 178 177 361 36.6  
EBIT  161 -63.0 -43.0 120 -226  
Pre-tax profit (PTP)  147.0 -64.0 -44.0 118.9 -234.4  
Net earnings  113.0 -57.0 -28.0 91.1 -184.5  
Pre-tax profit without non-rec. items  147 -64.0 -44.0 119 -234  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  452 398 313 160 368  
Shareholders equity total  163 31.0 3.0 94.0 -90.5  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 250  
Balance sheet total (assets)  1,396 1,497 1,026 998 1,202  
Net Debt  -250 -35.0 -177 -320 2.9  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,972 3,102 2,963 2,719 2,573  
Gross profit growth  0.0% -21.9% -4.5% -8.2% -5.4%  
Employees  6 7 6 7 5  
Employee growth %  0.0% 16.7% -14.3% 16.7% -28.6%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,396 1,497 1,026 998 1,202  
Balance sheet change%  0.0% 7.2% -31.5% -2.7% 20.4%  
Added value  408.0 178.0 177.0 339.7 36.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  529 -352 -362 -452 -112  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 -2.0 1.0 -1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.1% -2.0% -1.5% 4.4% -8.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  11.5% -4.3% -3.3% 11.9% -19.5%  
ROI %  91.0% -33.0% -41.6% 248.5% -130.0%  
ROE %  69.3% -58.8% -164.7% 187.8% -28.5%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  11.7% 2.1% 0.3% 9.4% -7.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -61.3% -19.7% -100.0% -88.6% 7.8%  
Gearing %  0.0% 0.0% 0.0% 0.0% -276.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 8.4%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.3 0.4 0.2 0.5 0.3  
Current Ratio  0.5 0.6 0.5 0.7 0.7  
Cash and cash equivalent  250.0 35.0 177.0 319.9 247.5  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -608.0 -495.0 -549.0 -247.2 -371.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  68 25 30 49 7  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  68 25 30 52 7  
EBIT / employee  27 -9 -7 17 -45  
Net earnings / employee  19 -8 -5 13 -37